Naprobene (Naproxen)

Naproxen, the active ingredient in Naprobene, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral administration. It is used to alleviate mild to moderate pain, diminish inflammation, and reduce fever in a range of conditions affecting adults and, when indicated, children.

GNH USA supplies Naprobene as a licensed, Good Distribution Practice‑compliant product, providing reliable bulk or packaged supply to hospitals, pharmacies and clinics across international markets. All shipments meet applicable EU pharmacopeial standards and are supported by full regulatory documentation.

Naproxen is an NSAID that reduces prostaglandin‑mediated inflammation and is indicated for several painful and inflammatory conditions. - Pain: Provides relief of mild to moderate acute pain such as dental, musculoskeletal, or postoperative discomfort. - Fever: Lowers elevated body temperature associated with febrile illnesses. - Osteoarthritis: Improves joint function and reduces stiffness in degenerative joint disease. - Rheumatoid arthritis: Decreases joint swelling and pain in chronic inflammatory arthritis. - Acute gout attacks: Alleviates pain and inflammation during sudden gout flares.

Naproxen may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal upset: dyspepsia, nausea, or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Rash: mild skin irritation or erythema.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding, which can be life‑threatening. - Cardiovascular events such as myocardial infarction or stroke, especially with long‑term use. - Renal impairment or acute kidney injury, particularly in patients with pre‑existing kidney disease. - Severe skin reactions, including Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: rare but potentially fatal allergic reaction.

Before initiating Naprobene therapy, consider the following safety measures. - Assess gastrointestinal risk: evaluate history of ulcers or bleeding before use. - Monitor cardiovascular status: avoid in patients with uncontrolled hypertension or recent myocardial infarction. - Check renal function: use cautiously in impaired kidney function. - Avoid concurrent use with other NSAIDs or anticoagulants unless medically necessary. - Store at ambient temperature: keep in original container, protect from moisture and light.

Naproxen can interact with several medicines; understanding the level of risk helps guide safe co‑administration.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency.

Moderate Interactions (Monitor Closely): - Diuretics: may reduce renal perfusion, enhancing nephrotoxicity. - Antihypertensives (e.g., ACE inhibitors, beta‑blockers): possible attenuation of blood‑pressure‑lowering effect. - Methotrexate: naproxen can decrease clearance, raising toxicity risk.